Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pain 12Neoplasms 11Cancer Pain 8Neuralgia 2Inflammation 2Head and Neck Neoplasms 2Bronchiolitis Obliterans Syndrome 2Agnosia 2Urinary Tract Infections 1Trigger Finger Disorder 1Stomatitis 1Staphylococcal Infections 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Pneumonia 1Osteoarthritis 1Nutrition Disorders 1Non Cancer Pain 1Neutropenia 1Nasopharyngeal Carcinoma 1Multiple Pulmonary Nodules 1

Interventions

alvimopan 5methylnaltrexone 1isatuximab 1Videotape Recording 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Standard of Care 1Proteins 1Oxycodone 1Octreotide 1Naloxone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Constipation × Oxycodone × Clear all
NCT00513656 2018-10-23

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Mundipharma Research GmbH & Co KG

Phase 2 Completed
230 enrolled
Other

Bronchiolitis Obliterans Syndrome, Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡